ArticleTranslational lung cancer research2025

Real-world comparison of neoadjuvant pembrolizumab plus chemotherapy versus tislelizumab plus chemotherapy in patients with resectable non-small cell lung cancer: a retrospective cohort study of treatment outcomes.

Yan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.